Comprehensive early intervention for patients with first-episode psychosis in Japan (J-CAP): Study protocol for a randomised controlled trial

Trials

Volumn 12, Issue , 2011, Pages

  Koike, Shinsuke ^a   Nishida, Atsushi ^b,c   Yamasaki, Syudo ^a,d   Ichihashi, Kayo ^e   Maegawa, Sanae ^f   Natsubori, Tatsunobu ^a   Harima, Hirohiko ^c   Kasai, Kiyoto ^a   Fujita, Izumi ^e   Harada, Masanori ^f   Okazaki, Yuji ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c TOKYO METROPOLITAN MATSUZAWA HOSPITAL   (Japan)

^d UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^e Hinaga General Center for Mental Care and Sasagawa Clinic   (Japan)

^f Mie Psychiatric Mental Care Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE MANAGEMENT; CLINICAL PROTOCOL; COGNITIVE THERAPY; COMMUNITY CARE; CONVALESCENCE; COST EFFECTIVENESS ANALYSIS; EARLY INTERVENTION; FAMILY THERAPY; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; INTERVENTION STUDY; JAPAN; PATIENT SELECTION; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAMPLE SIZE; SINGLE BLIND PROCEDURE; ADOLESCENT; ADULT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH CARE COST; MENTAL HEALTH SERVICE; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PATIENT CARE; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CASE MANAGEMENT; COMBINED MODALITY THERAPY; COMMUNITY MENTAL HEALTH SERVICES; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HUMANS; JAPAN; PATIENT CARE TEAM; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; QUESTIONNAIRES; RESEARCH DESIGN; SINGLE-BLIND METHOD; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79959258916     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-12-156     Document Type: Article

References (36)

1. iFEVR Meaningful lives: Supporting young people with psychosis in education, training and employment: an international consensus statement. Early Interv Psychiatry 2010, 4(4):323-326. iFEVR.
2. van Os J, Kapur S. Schizophrenia. Lancet 2009, 374(9690):635-645. 10.1016/S0140-6736(09)60995-8, 19700006.
3. Barton GR, Hodgekins J, Mugford M, Jones PB, Croudace T, Fowler D. Cognitive behaviour therapy for improving social recovery in psychosis: cost-effectiveness analysis. Schizophr Res 2009, 112(1-3):158-163. 10.1016/j.schres.2009.03.041, 19403270.
4. Patterson TL, Leeuwenkamp OR. Adjunctive psychosocial therapies for the treatment of schizophrenia. Schizophr Res 2008, 100(1-3):108-119. 10.1016/j.schres.2007.12.468, 18226500.
5. Petersen L, Jeppesen P, Thorup A, Abel MB, Ohlenschlaeger J, Christensen TO, Krarup G, Jorgensen P, Nordentoft M. A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness. BMJ 2005, 331(7517):602.. 10.1136/bmj.38565.415000.E01, 1215551, 16141449.
6. Craig TK, Garety P, Power P, Rahaman N, Colbert S, Fornells-Ambrojo M, Dunn G. The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis. BMJ 2004, 329(7474):1067.. 10.1136/bmj.38246.594873.7C, 526115, 15485934.
7. Garety PA, Craig TK, Dunn G, Fornells-Ambrojo M, Colbert S, Rahaman N, Read J, Power P. Specialised care for early psychosis: symptoms, social functioning and patient satisfaction: randomised controlled trial. Br J Psychiatry 2006, 188:37-45. 10.1192/bjp.bp.104.007286, 16388068.
8. Bird V, Premkumar P, Kendall T, Whittington C, Mitchell J, Kuipers E. Early intervention services, cognitive-behavioural therapy and family intervention in early psychosis: systematic review. Br J Psychiatry 2010, 197:350-356. 10.1192/bjp.bp.109.074526, 2966501, 21037211.
9. McCrone P, Craig TK, Power P, Garety PA. Cost-effectiveness of an early intervention service for people with psychosis. Br J Psychiatry 2010, 196(5):377-382. 10.1192/bjp.bp.109.065896, 20435964.
10. Oshima I, Mino Y, Inomata Y. How many long-stay schizophrenia patients can be discharged in Japan?. Psychiatry Clin Neurosci 2007, 61(1):71-77. 10.1111/j.1440-1819.2007.01613.x, 17239042.
11. World Health Organization International Statistical Classification of Diseases and Related Health Problems 10 th Revision 2003, World Health Organization.
12. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13(2):261-276.
13. Uetsuki M, Matsuoka K, Kasai K, Araki T, Suga M, Yamasue H, Maeda K, Yamazaki S, Furukawa S, Iwanami A, et al. Estimation of Premorbid IQ by Shortened Version of JARTs in Schizophrenia. Seishin Igaku 2007, 49(1):17-23.
14. Matsuoka K, Uno M, Kasai K, Koyama K, Kim Y. Estimation of premorbid IQ in individuals with Alzheimer's disease using Japanese ideographic script (Kanji) compound words: Japanese version of National Adult Reading Test. Psychiatry Clin Neurosci 2006, 60(3):332-339. 10.1111/j.1440-1819.2006.01510.x, 16732750.
15. Morrison AP, French P, Walford L, Lewis SW, Kilcommons A, Green J, Parker S, Bentall RP. Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br J Psychiatry 2004, 185:291-297. 10.1192/bjp.185.4.291, 15458988.
16. Bechdolf A, Knost B, Nelson B, Schneider N, Veith V, Yung AR, Pukrop R. Randomized comparison of group cognitive behaviour therapy and group psychoeducation in acute patients with schizophrenia: effects on subjective quality of life. Aust N Z J Psychiatry 2010, 44(2):144-150. 10.3109/00048670903393571, 20113303.
17. Rummel-Kluge C, Schuster T, Peters S, Kissling W. Partial compliance with antipsychotic medication is common in patients with schizophrenia. Aust N Z J Psychiatry 2008, 42(5):382-388. 10.1080/00048670801961107, 18473256.
18. Rummel-Kluge C, Pitschel-Walz G, Bauml J, Kissling W. Psychoeducation in schizophrenia--results of a survey of all psychiatric institutions in Germany, Austria, and Switzerland. Schizophr Bull 2006, 32(4):765-775. 2632267, 16844723.
19. Pharoah F, Mari J, Rathbone J, Wong W. Family intervention for schizophrenia. Cochrane Database Syst Rev 2010, (12):CD000088.
20. Gleeson JF, Cotton SM, Alvarez-Jimenez M, Wade D, Crisp K, Newman B, Spiliotacopoulos D, McGorry PD. Family outcomes from a randomized control trial of relapse prevention therapy in first-episode psychosis. J Clin Psychiatry 2010, 71(4):475-483. 10.4088/JCP.08m04672yel, 20021994.
21. Garety PA, Fowler DG, Freeman D, Bebbington P, Dunn G, Kuipers E. Cognitive--behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. Br J Psychiatry 2008, 192(6):412-423. 10.1192/bjp.bp.107.043570, 18515890.
22. Lim DS, Kang MS, Jeong JA, Bae YS. Semi-mature DC are immunogenic and not tolerogenic when inoculated at a high dose in collagen-induced arthritis mice. Eur J Immunol 2009, 39(5):1334-1343. 10.1002/eji.200838987, 19350558.
23. Gafoor R, Nitsch D, McCrone P, Craig TK, Garety PA, Power P, McGuire P. Effect of early intervention on 5-year outcome in non-affective psychosis. Br J Psychiatry 2010, 196(5):372-376. 10.1192/bjp.bp.109.066050, 20435962.
24. Bertelsen M, Jeppesen P, Petersen L, Thorup A, Ohlenschlaeger J, le Quach P, Christensen TO, Krarup G, Jorgensen P, Nordentoft M. Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness: the OPUS trial. Arch Gen Psychiatry 2008, 65(7):762-771. 10.1001/archpsyc.65.7.762, 18606949.
25. American Psychiatry Association Diagnostic and Statistical Manual of Mental Disorders 1994, Washington, D.C. U.S.A.: American Psychiatric Press, 4, American Psychiatry Association.
26. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med 1998, 28(3):551-558.
27. Tazaki M, Nakane Y. WHOQOL 26 Japanese Version 1997, Tokyo: Kaneko Shobo Press.
28. Dolder CR, Lacro JP, Warren KA, Golshan S, Perkins DO, Jeste DV. Brief evaluation of medication influences and beliefs: development and testing of a brief scale for medication adherence. J Clin Psychopharmacol 2004, 24(4):404-409. 10.1097/01.jcp.0000130554.63254.3a, 15232332.
29. Hall RC. Global assessment of functioning. A modified scale. Psychosomatics 1995, 36(3):267-275.
30. Early Intervention Yorkshire and Humber. , http://its-services.org.uk/earlyintervention/resources/
31. Andreasen NC, Carpenter WT, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005, 162(3):441-449. 10.1176/appi.ajp.162.3.441, 15741458.
32. Lambert M, Bock T, Schottle D, Golks D, Meister K, Rietschel L, Bussopulos A, Frieling M, Schodlbauer M, Burlon M, et al. Assertive community treatment as part of integrated care versus standard care: a 12-month trial in patients with first- and multiple-episode schizophrenia spectrum disorders treated with quetiapine immediate release (ACCESS trial). J Clin Psychiatry 2010, 71(10):1313-1323. 10.4088/JCP.09m05113yel, 20361911.
33. Beecham J, Knapp M. Costing psychiatric interventions. Measuring Mental Health Needs 2001, 200-224. London: Royal College of Psychiatrists, G T, 2.
34. Erdfelder E, Faul F, Buchner A. GPOWER: A general power analysis program. Behavior Research Methods, Instruments, & Computers 1996, 28:1-11. 10.3758/BF03203630, 21679426.
35. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979, 35:549-556. 10.2307/2530245, 497341.
36. Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med 2010, 8:18. 10.1186/1741-7015-8-18, 2860339, 20334633.